7 117 116 Directors’ Report for the year ended 31 March 2023 Directors’ Report for the year ended 31 March 2023 DIRECTORS’ INTERESTS IN SHARES (CONTINUED) Number of ordinary shares At 1.4.2022 Bought Sold At 31.3.2023 Shareholdings in the Company which Directors have deemed interests: Chia Song Kun 1,003,822,371 67,300 (994,100) 1,002,895,571 Chia Song Kooi 4,727,560 - - 4,727,560 Chia Seong Pow 293,815,796 42,570 (844,100) 293,014,266 Chia Song Swa 4,233,900 14,000 - 4,247,900 Chia Lik Khai 285,480 - - 285,480 Chia Seong Fatt 290,667,979 37,200 (844,100) 289,861,079 Chia Mak Hooi 713,700 - - 713,700 Cheah Juw Teck 2,298,000 - - 2,298,000 Kow Poh Gek 13,845 - - 13,845 Low Teng Lum 125,825 10,000 - 135,825 By virtue of his interest in the shares of the Company, Chia Song Kun is also deemed interested in the shares of all subsidiaries disclosed in Note 34 to these financial statements to the extent that the Company has an interest. The other Directors, Datin Paduka Setia Dato’ Dr. Aini Binti Ideris, Chan Wai Yen, Cynthia Toh Mei Lee, Wee Beng Chuan and Tan Ler Chin holding office at 31 March 2023 did not have any interest in the ordinary shares of the Company and of its related companies during the financial year. DIRECTORS’ BENEFITS Since the end of the previous financial year, no Director of the Company has received nor become entitled to receive any benefit (other than those shown below) by reason of a contract made by the Company or a related corporation with the Director or with a firm of which the Director is a member, or with a company in which the Director has a substantial financial interest, other than certain Directors who have substantial financial interests in companies which traded with certain companies in the Group in the ordinary course of business as disclosed in Note 33 to the financial statements. The Directors’ benefits paid to or receivable by Directors in respect of the financial year ended 31 March 2023 are as follows: From the Company RM’000 From subsidiary companies RM’000 Directors of the Company: Fees 1,298 1,935 Remuneration 39 19,043 Other short-term employee benefits (including estimated monetary value of any benefits-in-kind) - 205 1,337 21,183 There were no arrangements during and at the end of the financial year which had the object of enabling Directors of the Company to acquire benefits by means of the acquisition of shares in or debentures of the Company or any other body corporate. ISSUE OF SHARES AND DEBENTURES There were no changes in the issued and paid-up capital of the Company during the financial year. There were no debentures issued during the financial year. OPTIONS GRANTED OVER UNISSUED SHARES No options were granted to any person to take up unissued shares of the Company during the financial year. SHARE BUY-BACK The shareholders of the Company, by an ordinary resolution passed in the Annual General Meeting held on 30 August 2022, renewed the Company’s plan to buy-back its own shares. There was no share buy-back during the financial year. INDEMNITY AND INSURANCE COSTS The following disclosure on particulars of indemnity given to, or insurance effected for, any Director or officer of the Company is made pursuant to Section 289(7) of the Companies Act 2016: Amount paid RM Sum insured RM Directors and Officers Liability Insurance 29,384 20,000,000 There was no indemnity given to, or insurance effected for auditors of the Company during the financial year. OTHER STATUTORY INFORMATION Before the financial statements of the Group and of the Company were made out, the Directors took reasonable steps to ascertain that: i) all known bad debts have been written off and adequate provision made for doubtful debts, and ii) any current assets which were unlikely to be realised in the ordinary course of business have been written down to an amount which they might be expected so to realise. At the date of this report, the Directors are not aware of any circumstances: i) that would render the amount written off for bad debts or the amount of the provision for doubtful debts in the Group and in the Company inadequate to any substantial extent, or ii) that would render the value attributed to the current assets in the financial statements of the Group and of the Company misleading, or iii) which have arisen which render adherence to the existing method of valuation of assets or liabilities of the Group and of the Company misleading or inappropriate, or iv) not otherwise dealt with in this report or the financial statements that would render any amount stated in the financial statements of the Group and of the Company misleading.
RkJQdWJsaXNoZXIy NTkwNzg=